We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is a Disappointment in Store for Nu Skin (NUS) Q2 Earnings?
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) is scheduled to release second-quarter 2019 results on Aug 6. This cosmetics company’s earnings outperformed the Zacks Consensus Estimate by average of 7.1% in the trailing four quarters.
Let’s see what’s in store for the company this time around.
What to Expect?
The Zacks Consensus Estimate for second-quarter earnings, which has moved down in the past 30 days to 83 cents, suggests a 23.1% decline from the year-ago figure. The consensus mark for revenues is $633 million, implying a decline of 10.1% from the year-ago quarter’s reported figure.
Factors to Note
The 100-day government campaign in Mainland China to inspect offerings of direct selling industries and health products is likely to have adversely impacted Nu Skin’s performance in the second quarter. Constant media scrutiny and limitations on sales meetings have also hurt consumers’ sentiment, which in turn is likely to hurt the company’s performance. Moreover, adverse currency fluctuations have possibly been a threat.
Nevertheless, the company’s efforts to strengthen the customer base and network of sales leaders are likely to drive revenues. Nu Skin’s focus on its three key pillars — Products, Programs and Platform — also bodes well.
Management expects revenues for the second quarter to be $622-$623 million compared with $704 million recorded in the year-ago period. Earnings are envisioned to be 82-84 cents per share.
What the Zacks Model Unveils
Our proven model doesn’t show a beat for Nu Skin this earnings season. For this to happen, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Nu Skin has an Earnings ESP of 0.00% and a Zacks Rank #5 (Strong Sell). We caution against sell-rated stocks going into the earnings announcement.
General Mills (GIS - Free Report) has an Earnings ESP of +0.87% and a Zacks Rank #2.
Kraft Heinz (KHC - Free Report) has an Earnings ESP of +8.00% and a Zacks Rank #3.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
Is a Disappointment in Store for Nu Skin (NUS) Q2 Earnings?
Nu Skin Enterprises, Inc. (NUS - Free Report) is scheduled to release second-quarter 2019 results on Aug 6. This cosmetics company’s earnings outperformed the Zacks Consensus Estimate by average of 7.1% in the trailing four quarters.
Nu Skin Enterprises, Inc. Price and EPS Surprise
Nu Skin Enterprises, Inc. price-eps-surprise | Nu Skin Enterprises, Inc. Quote
Let’s see what’s in store for the company this time around.
What to Expect?
The Zacks Consensus Estimate for second-quarter earnings, which has moved down in the past 30 days to 83 cents, suggests a 23.1% decline from the year-ago figure. The consensus mark for revenues is $633 million, implying a decline of 10.1% from the year-ago quarter’s reported figure.
Factors to Note
The 100-day government campaign in Mainland China to inspect offerings of direct selling industries and health products is likely to have adversely impacted Nu Skin’s performance in the second quarter. Constant media scrutiny and limitations on sales meetings have also hurt consumers’ sentiment, which in turn is likely to hurt the company’s performance. Moreover, adverse currency fluctuations have possibly been a threat.
Nevertheless, the company’s efforts to strengthen the customer base and network of sales leaders are likely to drive revenues. Nu Skin’s focus on its three key pillars — Products, Programs and Platform — also bodes well.
Management expects revenues for the second quarter to be $622-$623 million compared with $704 million recorded in the year-ago period. Earnings are envisioned to be 82-84 cents per share.
What the Zacks Model Unveils
Our proven model doesn’t show a beat for Nu Skin this earnings season. For this to happen, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Nu Skin has an Earnings ESP of 0.00% and a Zacks Rank #5 (Strong Sell). We caution against sell-rated stocks going into the earnings announcement.
Stocks Poised to Beat Earnings Estimates
Estee Lauder (EL - Free Report) has an Earnings ESP of +2.46% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
General Mills (GIS - Free Report) has an Earnings ESP of +0.87% and a Zacks Rank #2.
Kraft Heinz (KHC - Free Report) has an Earnings ESP of +8.00% and a Zacks Rank #3.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>